ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹732 Cr | ₹753 Cr | ₹801 Cr | ₹656 Cr | ₹657 Cr |
What is the latest Contingent Liabilities ratio of ZYDUS LIFESCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹732 Cr |
| Mar2024 | ₹753 Cr |
| Mar2023 | ₹801 Cr |
| Mar2022 | ₹656 Cr |
| Mar2021 | ₹657 Cr |
How is Contingent Liabilities of ZYDUS LIFESCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹732 Cr | -2.84 | |
| Mar2024 | ₹753 Cr | -5.98 | |
| Mar2023 | ₹801 Cr | 22.19 | |
| Mar2022 | ₹656 Cr | -0.24 | |
| Mar2021 | ₹657 Cr | - | |
Compare Contingent Liabilities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹91,247.2 Cr | 1.6% | 4.2% | 6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | 1.6% |
4.2% |
6% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses